Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis

Transthyretin amyloidosis (ATTR amyloidosis) is a fatal systemic disease caused by amyloid deposits of misfolded transthyretin, leading to familial amyloid polyneuropathy and/or cardiomyopathy, or a rare oculoleptomeningeal amyloidosis. A good model system that mimic the disease phenotype is crucial...

Full description

Bibliographic Details
Main Authors: Ridwan Babatunde Ibrahim, Yo-Tsen Liu, Ssu-Yu Yeh, Jin-Wu Tsai
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2019.00338/full
_version_ 1818009443855499264
author Ridwan Babatunde Ibrahim
Ridwan Babatunde Ibrahim
Yo-Tsen Liu
Yo-Tsen Liu
Yo-Tsen Liu
Yo-Tsen Liu
Ssu-Yu Yeh
Jin-Wu Tsai
Jin-Wu Tsai
author_facet Ridwan Babatunde Ibrahim
Ridwan Babatunde Ibrahim
Yo-Tsen Liu
Yo-Tsen Liu
Yo-Tsen Liu
Yo-Tsen Liu
Ssu-Yu Yeh
Jin-Wu Tsai
Jin-Wu Tsai
author_sort Ridwan Babatunde Ibrahim
collection DOAJ
description Transthyretin amyloidosis (ATTR amyloidosis) is a fatal systemic disease caused by amyloid deposits of misfolded transthyretin, leading to familial amyloid polyneuropathy and/or cardiomyopathy, or a rare oculoleptomeningeal amyloidosis. A good model system that mimic the disease phenotype is crucial for the development of drugs and treatments for this devastating degenerative disorder. The present models using fruit flies, worms, rodents, non-human primates and induced pluripotent stem cells have helped researchers understand important disease-related mechanisms and test potential therapeutic options. However, the challenge of creating an ideal model still looms, for these models did not recapitulates all symptoms, particularly neurological presentation, of ATTR amyloidosis. Recently, knock-in techniques was used to generate two humanized ATTR mouse models, leading to amyloid deposition in the nerves and neuropathic manifestation in these models. This review gives a recent update on the milestone, progress, and challenges in developing different models for ATTR amyloidosis research.
first_indexed 2024-04-14T05:42:01Z
format Article
id doaj.art-49f484de64394bc5ae95880dad011bb3
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-04-14T05:42:01Z
publishDate 2019-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-49f484de64394bc5ae95880dad011bb32022-12-22T02:09:24ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2019-04-011010.3389/fphys.2019.00338441908Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin AmyloidosisRidwan Babatunde Ibrahim0Ridwan Babatunde Ibrahim1Yo-Tsen Liu2Yo-Tsen Liu3Yo-Tsen Liu4Yo-Tsen Liu5Ssu-Yu Yeh6Jin-Wu Tsai7Jin-Wu Tsai8Institute of Brain Science, School of Medicine, National Yang-Ming University, Taipei, TaiwanTaiwan International Graduate Program in Interdisciplinary Neuroscience, National Yang-Ming University and Academia Sinica, Taipei, TaiwanInstitute of Brain Science, School of Medicine, National Yang-Ming University, Taipei, TaiwanDepartment of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, TaiwanDepartment of Medicine, School of Medicine, National Yang-Ming University, Taipei, TaiwanBrain Research Center and Biophotonics and Molecular Imaging Research Center, National Yang-Ming University, Taipei, TaiwanInstitute of Brain Science, School of Medicine, National Yang-Ming University, Taipei, TaiwanInstitute of Brain Science, School of Medicine, National Yang-Ming University, Taipei, TaiwanBrain Research Center and Biophotonics and Molecular Imaging Research Center, National Yang-Ming University, Taipei, TaiwanTransthyretin amyloidosis (ATTR amyloidosis) is a fatal systemic disease caused by amyloid deposits of misfolded transthyretin, leading to familial amyloid polyneuropathy and/or cardiomyopathy, or a rare oculoleptomeningeal amyloidosis. A good model system that mimic the disease phenotype is crucial for the development of drugs and treatments for this devastating degenerative disorder. The present models using fruit flies, worms, rodents, non-human primates and induced pluripotent stem cells have helped researchers understand important disease-related mechanisms and test potential therapeutic options. However, the challenge of creating an ideal model still looms, for these models did not recapitulates all symptoms, particularly neurological presentation, of ATTR amyloidosis. Recently, knock-in techniques was used to generate two humanized ATTR mouse models, leading to amyloid deposition in the nerves and neuropathic manifestation in these models. This review gives a recent update on the milestone, progress, and challenges in developing different models for ATTR amyloidosis research.https://www.frontiersin.org/article/10.3389/fphys.2019.00338/fulltransthyretinfamilial amyloid polyneuropathyC. elegansD. melanogastertransgenic mouseiPSC
spellingShingle Ridwan Babatunde Ibrahim
Ridwan Babatunde Ibrahim
Yo-Tsen Liu
Yo-Tsen Liu
Yo-Tsen Liu
Yo-Tsen Liu
Ssu-Yu Yeh
Jin-Wu Tsai
Jin-Wu Tsai
Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis
Frontiers in Physiology
transthyretin
familial amyloid polyneuropathy
C. elegans
D. melanogaster
transgenic mouse
iPSC
title Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis
title_full Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis
title_fullStr Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis
title_full_unstemmed Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis
title_short Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis
title_sort contributions of animal models to the mechanisms and therapies of transthyretin amyloidosis
topic transthyretin
familial amyloid polyneuropathy
C. elegans
D. melanogaster
transgenic mouse
iPSC
url https://www.frontiersin.org/article/10.3389/fphys.2019.00338/full
work_keys_str_mv AT ridwanbabatundeibrahim contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis
AT ridwanbabatundeibrahim contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis
AT yotsenliu contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis
AT yotsenliu contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis
AT yotsenliu contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis
AT yotsenliu contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis
AT ssuyuyeh contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis
AT jinwutsai contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis
AT jinwutsai contributionsofanimalmodelstothemechanismsandtherapiesoftransthyretinamyloidosis